Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The International Journal of Biochemistry & Cell Biology
|
August 22, 2020
Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation Therapy
William A Hall, Lavannya Sabharwal, Vindhya Udhane, et al.
FEBS Letters
|
July 7, 2015
Cellular stress induces cap-independent alpha-enolase/MBP-1 translation
Cristina Maranto, Giovanni Perconti, Flavia Contino, et al.
Scientific Reports
|
June 21, 2017
Pro-invasive stimuli and the interacting protein Hsp70 favour the route of alpha-enolase to the cell surface
Giovanni Perconti, Cristina Maranto, Daniele P Romancino, et al.
Clinical and Experimental Rheumatology
|
December 21, 2019
Fingerprinting of anti-alpha enolase antibodies in systemic sclerosis
Giovanni Perconti, Federico Pratesi, Francesca Angelotti, et al.
Cancers
|
October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Molecular Cancer Therapeutics
|
September 25, 2019
Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors
Vindhya Udhane, Cristina Maranto, David T Hoang, et al.
Cancers
|
March 28, 2025
Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. <i>Cancers</i> 2020, <i>12</i>, 3412
Cristina Maranto, Vindhya Udhane, Jing Jia, et al.
Science Advances
|
February 28, 2024
Stat5 induces androgen receptor (<i>AR</i>) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling
Cristina Maranto, Lavannya Sabharwal, Vindhya Udhane, et al.
Cancers
|
November 21, 2020
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo
Cristina Maranto, Vindhya Udhane, Jing Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Cristina Maranto, Vindhya Udhane, David T Hoang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The International Journal of Biochemistry & Cell Biology
|
August 22, 2020
Cytokines, JAK-STAT Signaling and Radiation-Induced DNA Repair in Solid Tumors: Novel Opportunities for Radiation Therapy
William A Hall, Lavannya Sabharwal, Vindhya Udhane, et al.
FEBS Letters
|
July 7, 2015
Cellular stress induces cap-independent alpha-enolase/MBP-1 translation
Cristina Maranto, Giovanni Perconti, Flavia Contino, et al.
Scientific Reports
|
June 21, 2017
Pro-invasive stimuli and the interacting protein Hsp70 favour the route of alpha-enolase to the cell surface
Giovanni Perconti, Cristina Maranto, Daniele P Romancino, et al.
Clinical and Experimental Rheumatology
|
December 21, 2019
Fingerprinting of anti-alpha enolase antibodies in systemic sclerosis
Giovanni Perconti, Federico Pratesi, Francesca Angelotti, et al.
Cancers
|
October 23, 2021
Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?
Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.
Molecular Cancer Therapeutics
|
September 25, 2019
Enzalutamide-Induced Feed-Forward Signaling Loop Promotes Therapy-Resistant Prostate Cancer Growth Providing an Exploitable Molecular Target for Jak2 Inhibitors
Vindhya Udhane, Cristina Maranto, David T Hoang, et al.
Cancers
|
March 28, 2025
Correction: Maranto et al. Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. <i>Cancers</i> 2020, <i>12</i>, 3412
Cristina Maranto, Vindhya Udhane, Jing Jia, et al.
Science Advances
|
February 28, 2024
Stat5 induces androgen receptor (<i>AR</i>) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling
Cristina Maranto, Lavannya Sabharwal, Vindhya Udhane, et al.
Cancers
|
November 21, 2020
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo
Cristina Maranto, Vindhya Udhane, Jing Jia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2018
STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair
Cristina Maranto, Vindhya Udhane, David T Hoang, et al.
Page
of 1